Fidelity Investments’s Theriva Biologics TOVX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $1.3K | Buy |
+3,000
| New | +$1.3K | ﹤0.01% | 4928 |
|
|
2024
Q3 | – | Sell |
-20
| Closed | -$118 | – | 5729 |
|
|
2024
Q2 | $118 | Buy |
+20
| New | +$118 | ﹤0.01% | 4953 |
|
|
2024
Q1 | – | Hold |
0
| – | -$4 | – | 5302 |
|
|
2023
Q4 | – | Sell |
-4
| Closed | -$54 | – | 5380 |
|
|
2023
Q3 | $54 | Buy |
+4
| New | +$54 | ﹤0.01% | 4922 |
|
|
2023
Q1 | – | Hold |
0
| – | -$4 | – | 5523 |
|
|
2022
Q4 | – | Hold |
0
| – | – | – | 5299 |
|
|
2022
Q3 | – | Sell |
-4
| Closed | – | – | 5410 |
|
|
2022
Q2 | $0 | Buy |
4
+3
| +300% | – | ﹤0.01% | 5486 |
|
|
2022
Q1 | $0 | Buy |
+1
| New | – | ﹤0.01% | 5484 |
|
|
2020
Q4 | – | Hold |
0
| – | – | – | 4280 |
|
|
2020
Q3 | – | Sell |
-1
| Closed | – | – | 3995 |
|
|
2020
Q2 | $0 | Buy |
+1
| New | – | ﹤0.01% | 4161 |
|